Twin Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Twin Capital Management's DGX Position: Q2 2024 in Review
Twin Capital Management sold out of Quest Diagnostics (DGX) in Q2 2024, closing a stake of 4,887 shares — an estimated $651K sold.
Twin Capital Management first reported a position in DGX in Q1 2014 and held it in 22 quarters. The position peaked at $5.59M in Q2 2017. 838 funds tracked by Wall St. Rank hold DGX as of Q2 2024.
- Twin Capital Management reported no remaining Quest Diagnostics position as of Q2 2024 after selling out during the quarter.
- Twin Capital Management sold 4,887 Quest Diagnostics shares in Q2 2024, an estimated $651K.
- Twin Capital Management first reported a position in Quest Diagnostics in Q1 2014 and held it in 22 quarters.
- Twin Capital Management's Quest Diagnostics position peaked at $5.59M in Q2 2017.
- 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2024.
Based on Twin Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.